Peptides DB
Research-centric peptide and protocol reference hub
Study 20 of 22IGF-1 DES (Des(1-3) IGF-1) literatureThe Journal of clinical endocrinology and metabolism · ObservationalHigh-impact journal1999

Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth.

The study indicates that growth hormone and insulin-like growth factor I can stimulate melanocyte growth in vitro, but clinical implications remain unclear.

Read at The Journal of clinical endocrinology and metabolismAdd to compare

Where it sits

this study against the rest of the igf-1 des (des(1-3) igf-1) corpus
2
Preclinical
16
Observational · this one
0
Open-label
3
Randomised
1
Reviews

Summary and findings

The study examined the role of growth hormone (GH) and insulin-like growth factor I (IGF-I), including des(1-3)IGF-I, in melanocyte growth in vitro. It was found that GH stimulates melanocyte growth when combined with IGF-I or des(1-3)IGF-I. The study also noted that IGF-I is more effective than des(1-3)IGF-I at low concentrations.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.1999

Abstract

The authors’ words, as The Journal of clinical endocrinology and metabolism supplied them

Melanocytes, highly differentiated neural crest-derived cells, are located in the basal layer of the epidermis, where they play a role in protecting against UV damage in the skin. Previous studies suggest that both growth hormone (GH) and the insulin-like growth factor I (GH/IGF-I) system may be important for melanocyte growth and function. We have therefore characterized the role of the GH/IGF system in melanocyte growth in vitro and its interaction with the local growth factor basic fibroblast growth factor (bFGF). Analysis of the effects of GH, IGF-I, and bFGF and combinations of these growth factors on melanocyte growth in vitro revealed that 1) GH stimulates the growth of melanocytes when combined with IGF-I, des(1-3)IGF-I [an analog of IGF-I that has a reduced binding affinity for IGF-binding proteins (IGFBPs)], or bFGF, either separately or in combination; 2) in contrast to the lack of effect of GH or bFGF alone, both IGF-I and des(1-3)IGF-I enhance melanocyte growth in a dose-dependent manner; and 3) IGF-I is more efficacious in eliciting a growth response at low concentrations compared to des(1-3)IGF-I. Using Western ligand blotting, affinity cross-linking, immunoprecipitation, RIA, and Northern analysis, we show that cultured human melanocytes synthesize and secrete minimal amounts of IGFBP. IGFBP-4 is the major IGFBP produced by these cells when cultured in complete growth medium or in the presence of either IGF-I or des(1-3)IGF-I alone. In conclusion, these studies provide support for a role for both GH and IGF-I in the growth of human melanocytes in vitro, involving synergy with bFGF. Low levels of melanocyte-derived IGFBP-4 may play a role in enhancing the modulation of IGF action.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the IGF-1 DES (Des(1-3) IGF-1) corpus

CDetection of LongR<sup>3</sup> -IGF-I, Des(1-3)-IGF-I, and R<sup>3</sup> -IGF-I using immunopurification and high resolution mass spectrometry for antidoping purposes.Drug testing and analysis · Des(1-3)-IGF-I and R<sup>3</sup>-IGF-I detectable until 24 h after 100 μg/kg IM injection in rats.AnimalBN-terminal truncated insulin-like growth factor-I in human urine.The Journal of clinical endocrinology and metabolism · 1995 · Total urinary IGF-I level was 216.0 +/- 41.1 ng/L (mean +/- SEM).HumanCThe role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers.The Journal of clinical endocrinology and metabolism · 2004 · Not reported in abstract.In vitroBPost-Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study.DEN open · 2023 · n=102 · 8% of patients experienced bleeding.HumanBBethesda Endoscopic Retrograde Cholangiopancreatography Skill Assessment Tool (BESAT)-Based Simulator Training Using a Novel Dry Endoscopic Retrograde Cholangiopancreatography Model Improves Technical Proficiency and Self-Efficacy: A Prospective Study.DEN open · 2026 · n=30 · EST success rate increased from 43.3% to 76.7% (p < 0.05).HumanDNeutrophil serine proteases inhibit thermogenic capacity of visceral white adipose tissue.Nature metabolism · 2026